Widening eligibility to phase II trials: constant arcsine difference phase II trialsA'HERN, Roger P.Controlled clinical trials. 2004, Vol 25, Num 3, pp 251-264, issn 0197-2456, 14 p.Article

A randomized, dose-finding, phase II study of the selective relaxant binding drug, sugammadex, capable of safely reversing profound rocuronium-lnduced neuromuscular blockGROUDINE, Scott B; SOTO, Roy; LIEN, Cynthia et al.Anesthesia and analgesia. 2007, Vol 104, Num 3, pp 555-562, issn 0003-2999, 8 p.Article

Phase II and pharmacokinetic study of aziridinylbenzoquinone [2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] in high-grade gliomas = Essai phase II et pharmacocinétique de l'aziridinylbenzoquinone [2,5-dioziridinyl-3,6-bis(carboéthoxyamino)-1,4-benzoquinone, diaziquone, NSC 182986] dans les gliomes de grade élevéCURT, G. A; KELLEY, J. A; KUFTA, C. V et al.Cancer research (Baltimore). 1983, Vol 43, Num 12, pp 6102-6105, issn 0008-5472Article

An early phase II trial with L-deprenyl for the treatment of neuroleptic-induced ParkinsonismPERENYI, A; BAGDY, G; ARATO, M et al.Pharmacopsychiatria. 1983, Vol 16, Num 5, pp 143-146, issn 0720-4280Article

Differential Roles of Phase I and Phase II Enzymes in 3,4-Methylendioxymethamphetamine-Induced CytotoxicityANTOLINO-LOBO, Irene; MEULENBELT, Jan; NIJMEIJER, Sandra M et al.Drug metabolism and disposition. 2010, Vol 38, Num 7, pp 1105-1112, issn 0090-9556, 8 p.Article

Novel Designs and End Points for Phase II Clinical Trials : Phase II Trials: Designs for the futureADJEI, Alex A; CHRISTIAN, Michaele; IVY, Percy et al.Clinical cancer research (Print). 2009, Vol 15, Num 6, pp 1866-1872, issn 1078-0432, 7 p.Article

A two-stage design for a phase II clinical trial of coenzyme Q10 in ALSLEVY, G; KAUFMANN, P; THOMPSON, J. L. P et al.Neurology. 2006, Vol 66, Num 5, pp 660-663, issn 0028-3878, 4 p.Article

Randomized phase II clinical trialsSIMON, R; WITTES, R. E; ELLENBERG, S. S et al.Cancer treatment reports. 1985, Vol 69, Num 12, pp 1375-1381, issn 0361-5960Article

Clinical drug development: an analysis of phase II trials, 1970-1985MARSONI, S; HOTH, D; SIMON, R et al.Cancer treatment reports. 1987, Vol 71, Num 1, pp 71-80, issn 0361-5960Article

PHASE II STUDY OF ANTINEOPLASTIC AGENTS IN JAPANMAJIMA H.1980; RECENT RESULTS CANCER RES.; DEU; DA. 1980; VOL. 70; PP. 61-65; BIBL. 7 REF.Conference Paper

Optimising the design of phase II oncology trials : The importance of randomisationRATAIN, Mark J; SARGENT, Daniel J.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 275-280, issn 0959-8049, 6 p.Article

A short report on highlights of worldwide development of RIX4414 : A Singaporean experiencePHUA, K. B; QUAK, S. H; EMMANUEL, S et al.Vaccine. 2006, Vol 24, Num 18, pp 3782-3783, issn 0264-410X, 2 p.Conference Paper

Why we should be wary of single-center trialsBELLOMO, Rinaldo; WARRILLOW, Stephen J; READE, Michael C et al.Critical care medicine. 2009, Vol 37, Num 12, pp 3114-3119, issn 0090-3493, 6 p.Article

Reversal of Profound, High-dose Rocuronium-induced Neuromuscular Blockade by Sugammadex at Two Different Time Points : An International, Multicenter, Randomized, Dose finding, Safety Assessor-blinded, Phase II TrialPUHRINGER, Friedrich K; REX, Christopher; SIELENKÄMPER, Andreas W et al.Anesthesiology (Philadelphia). 2008, Vol 109, Num 2, pp 188-197, issn 0003-3022, 10 p.Article

Safety and acceptability of the candidate microbicide Carraguard in Thai women : Findings from a phase II clinical trialKILMARX, Peter H; VAN DE WIJGERT, Janneke H. H. M; SUPAWITKUL, Somsak et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 3, pp 327-334, issn 1525-4135, 8 p.Article

Plans expérimentaux pour l'inclusion de patients dans les essais de phase II = Statisticals designs for phase II trialsKRAMAR, A; POTVIN, D; HILL, C et al.Revue d'épidémiologie et de santé publique. 1996, Vol 44, Num 4, pp 364-371, issn 0398-7620Article

Chemotherapy of diffuse malignant mesothelioma: phase II trials of single-agent 5-fluorouracil and adriamycinHARVEY, V. J; SLEVIN, M. L; PONDER, B. A. J et al.Cancer. 1984, Vol 54, Num 6, pp 961-964, issn 0008-543XArticle

Phase-II clinical trial of 4'-epi-doxorubicin in metastatic solid tumorsKOLARIC, K; POTREBICA, V; CERVEK, J et al.Journal of cancer research and clinical oncology. 1983, Vol 106, Num 2, pp 148-152, issn 0171-5216Article

PHASE II TRIAL OF AZIRIDINYLBENZOQUINONE (AZQ) IN PATIENTS WITH REFRACTORY LYMPHOMA = ESSAI PHASE II DE L'AZIRIDINYLBENZOQUINONE (AZQ) DANS LES LYMPHOMES REFRACTAIRESMCLAUGHLIN P; CABANILLAS F; BEDIKIAN AY et al.1983; CANCER TREATMENT REPORTS; ISSN 0361-5960; USA; DA. 1983; VOL. 67; NO 5; PP. 507-508; BIBL. 5 REF.; GRAPHArticle

PHASE II TRIAL OF PREDNIMUSTINE IN CHILDREN WITH RECURRENT CANCER: A CHILDREN'S CANCER STUDY GROUP REPORTGAYNON PS; BAUM ES; KRIVIT W et al.1982; CANCER TREAT. REP.; ISSN 0361-5960; USA; DA. 1982; VOL. 66; NO 7; PP. 1583-1584; BIBL. 5 REF.Article

PHASE II TRIALS OF METHYLGLYOXAL-BIS (GUANYLHYDRAZONE)KELSEN DP; YAGODA A; WARRELL R et al.1982; AM. J. CLIN. ONCOL.; ISSN 512273; USA; DA. 1982; VOL. 5; NO 2; PP. 221-225; BIBL. 16 REF.Article

PHASE II STUDY OF DIBROMODULCITOL IN COLORECTAL, KIDNEY, AND OTHER CARCINOMASMISCHLER NE; TORMEY DC; KLOTZ J et al.1981; CANCER CLIN. TRIALS; ISSN 0190-1206; USA; DA. 1981; VOL. 4; NO 4; PP. 407-410; BIBL. 11 REF.Article

THE CLINICAL EVALUATION OF ANALOGUES. IV: NITROSOUREASCARTER SK.1980; RECENT RESULTS CANCER RES.; DEU; DA. 1980; VOL. 70; PP. 119-123; BIBL. 6 REF.Conference Paper

CHIMIOTHERAPIE DES CANCERS PAR LE CIS-DIAMMINO-DICHLOROPLATINUM ESSAI THERAPEUTIQUE PHASE IIHAYAT M; BAYSSAS M; BRULE G et al.1979; NOUV. PRESSE MED.; FRA; DA. 1979; VOL. 8; NO 15; PP. 1231-1234; ABS. ENG; BIBL. 25 REF.Article

A phase II, double-blind, placebo-controlled, ascending-dose study of eritoran (E5564), a upid a antagonist, in patients undergoing cardiac surgery with cardiopulmonary bypassBENNETT-GUERRERO, Elliott; GROCOTT, Hilary P; LEVY, Jerrold H et al.Anesthesia and analgesia. 2007, Vol 104, Num 2, pp 378-383, issn 0003-2999, 6 p.Article